Phase III clinical study of SUN Y7017 Double blind controlled Study for safety evaluation of 1-step titration with 3-step titration in patients with moderate to severe Alzheimer's disease

Trial Profile

Phase III clinical study of SUN Y7017 Double blind controlled Study for safety evaluation of 1-step titration with 3-step titration in patients with moderate to severe Alzheimer's disease

Completed
Phase of Trial: Phase III

Latest Information Update: 01 Sep 2017

At a glance

  • Drugs Memantine (Primary)
  • Indications Alzheimer's disease
  • Focus Adverse reactions
  • Sponsors Daiichi Sankyo Company
  • Most Recent Events

    • 29 Aug 2017 Status changed from active, no longer recruiting to completed.
    • 19 Apr 2017 Status changed from not yet recruiting to active, no longer recruiting.
    • 27 May 2016 New trial record
Restricted Access

Oops, it looks like you don’t have a valid subscription to this content. To gain full access to the content and functionality of the AdisInsight database try one of the following.

  • with a username/password associated to an account with a valid subscription
  • Contact your organization’s admin about adding this content to your AdisInsight subscription
  • Request a trial

If you are a subscriber to this content then contact us at AsktheExpert.AdisInsight@springer.com so we can help.

Back to top